Michael Goldberg - May 10, 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ Peter Maag as attorney-in-fact for Michael Goldberg
Stock symbol
CDNA
Transactions as of
May 10, 2021
Transactions value $
-$4,333,533
Form type
4
Date filed
5/12/2021, 06:56 PM
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $45.5K +15.4K +26.4% $2.95 73.9K May 10, 2021 Direct
transaction CDNA Common Stock Sale -$403K -6.04K -8.17% $66.78 67.9K May 10, 2021 Direct F1
transaction CDNA Common Stock Sale -$12.6K -183 -0.27% $68.62 67.7K May 10, 2021 Direct F2
transaction CDNA Common Stock Sale -$649K -9.22K -13.61% $70.36 58.5K May 10, 2021 Direct F3
transaction CDNA Common Stock Options Exercise $145K +49.1K +83.9% $2.95 108K May 11, 2021 Direct
transaction CDNA Common Stock Sale -$1.11M -16.8K -15.61% $65.83 90.8K May 11, 2021 Direct F4
transaction CDNA Common Stock Sale -$1.08M -16.3K -17.96% $66.35 74.5K May 11, 2021 Direct F5
transaction CDNA Common Stock Sale -$836K -12.4K -16.64% $67.49 62.1K May 11, 2021 Direct F6
transaction CDNA Common Stock Sale -$245K -3.59K -5.78% $68.30 58.5K May 11, 2021 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Option to Purchase Common Stock Options Exercise -$45.5K -15.4K -23.93% $2.95 49.1K May 10, 2021 Common Stock 15.4K $2.95 Direct F8
transaction CDNA Option to Purchase Common Stock Options Exercise -$145K -49.1K -100% $2.95 0 May 11, 2021 Common Stock 49.1K $2.95 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.455 to $67.28, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.02 to $68.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.67 to $70.515, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.005 to $67.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.01 to $68.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.015 to $68.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F8 This option is subject to an early exercise provision and is immediately exercisable. 1/8th of the shares subject to the option vested on October 31, 2011 and 1/48th of the shares subject to the option vested monthly thereafter.